BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer. - Wikidata - wikimedia - TriplyDB

BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer.

BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer.

http://www.wikidata.org/entity/Q50547545

about

Identification of six pathogenic RAD51C mutations via mutational screening of 1228 Danish individuals with increased risk of hereditary breast and/or ovarian cancer Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study.Identification of a Danish breast/ovarian cancer family double heterozygote for BRCA1 and BRCA2 mutations.Functional characterization of BRCA1 gene variants by mini-gene splicing assay.New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing Germline BRCA1 mutations increase prostate cancer risk Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control.Common BRCA1 and BRCA2 mutations in breast cancer families: a meta-analysis from systematic review.The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise.A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members.Differing effects of adjuvant chemotherapy according to BRCA1 nuclear expression in gastric cancer.BRCA1 and BRCA2 mutation spectrum - an update on mutation distribution in a large cancer genetics clinic in Norway.A Danish national effort of BRCA1/2 variant classification.Clinical and molecular characterization of BRCA-associated breast cancer: results from the DBCG.DBCG: the Danish Breast Cancer Cooperative Group--a 30-year struggle for better breast cancer treatment in Denmark.A BRCA2 mutation incorrectly mapped in the original BRCA2 reference sequence, is a common West Danish founder mutation disrupting mRNA splicing.Screening of 1331 Danish breast and/or ovarian cancer families identified 40 novel BRCA1 and BRCA2 mutations.BRCA1/BRCA2 founder mutations and cancer risks: impact in the western Danish population.Identification of BRCA1-deficient ovarian cancers.

P2860

Q28271817-28F7A57C-90ED-41ED-A9E4-42F680DA1949 Q30433040-A83F2283-F293-4BAB-83FD-3B8A9FC50123 Q34065253-7025E06D-5A71-43E7-9071-F9C4973F2CD0 Q34508273-512C9568-162F-47B0-B51F-B7CDE2230A1E Q35600785-84BF274F-37E1-4820-9501-61FF1F8963A1 Q35949522-8ADE71B1-D880-488F-BDD9-AB2849CE32A2 Q36117690-FDA1D0BD-26EF-4F79-B99F-8FCC88992979 Q37885224-A69044D7-B5BD-475B-B8E4-6D9BAFE15152 Q38426636-FDFBAB40-912A-4C8F-BD5C-A34B20FDF71D Q42181679-4EABADFD-0047-4AA8-B21F-5F5ECA297E0E Q46145271-0484E6EF-4B5E-4232-A546-FD792A16A7AF Q46328116-C74CDA2F-8135-4D0C-94D1-37CD751EDE5D Q48534893-9592F676-8BAC-42EC-AA48-46FB8B23CF9B Q49718948-0863D4DC-6C8B-4C7A-83B7-6C68D64581D1 Q49818524-B0C188D9-B4F6-4D85-9137-C2EFFFCAACBF Q50547499-AD0DDA40-BA73-4C70-85C2-1B3EA3A222ED Q50552807-438FBA6E-52E9-4216-B169-D58DA9D15815 Q50553282-A7B925EE-7747-48D0-A5E7-512A424C4B55 Q50569587-DE0AFE70-7554-4D27-B9C9-87221B59D376 Q54384897-0FD797A0-555A-4929-9024-0B533950205C

P2860

BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer.

http://www.wikidata.org/entity/Q50547545

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

BRCA1 and BRCA2 mutations in D ...... breast and/or ovarian cancer.

@en

BRCA1 and BRCA2 mutations in D ...... breast and/or ovarian cancer.

@nl

type

label

BRCA1 and BRCA2 mutations in D ...... breast and/or ovarian cancer.

@en

BRCA1 and BRCA2 mutations in D ...... breast and/or ovarian cancer.

@nl

prefLabel

BRCA1 and BRCA2 mutations in D ...... breast and/or ovarian cancer.

@en

BRCA1 and BRCA2 mutations in D ...... breast and/or ovarian cancer.

@nl

P1433

Q50547545-A47691F9-5A94-46E2-983B-77E2282EE78E

P1476

Q50547545-648AAA9D-1D2D-4303-9CD4-92798C105BA4

P2093

Q50547545-010CC47D-0E8D-4BDE-86D6-59E2E98CF237

Q50547545-07EC21CA-3CE4-4C0C-8108-465CA043F0E9

Q50547545-20B44EB7-522A-4648-B904-5E41E1832577

Q50547545-382F1B72-CC67-4FC2-9847-0C468000A9B7

Q50547545-5CDF65D8-157D-4E07-8900-B3C998187156

Q50547545-838C49DB-98A0-4820-90C8-94239F038DF1

Q50547545-BEBEF992-0F0C-4154-A35D-85C0A31D47E0

Q50547545-CA0BF3C8-08EB-4229-95C9-042EE7E9E271

Q50547545-DAE0CCEA-720E-4CA9-813C-73988E203305

P2860

Q50547545-220672C3-7F58-458E-8B15-70823AEB02CF

Q50547545-4EDB1839-C0FA-4B7A-B57D-45BC9BAD1003

Q50547545-5BC44348-D6DA-49B7-9CDB-4BBB07333D2D

Q50547545-78D72F6C-C7A3-436F-BD7B-F69CE8801BA2

Q50547545-7C434F51-CEDB-46A5-A164-E13637BFB251

Q50547545-834B09B7-1DC8-4CA8-B0B9-53F62CC80E94

Q50547545-B38889E3-1D15-41A9-8A7F-656F73B0B4F8

Q50547545-C1557D1B-170E-4C96-BFE3-E3FC2A549653

Q50547545-C81BF413-264C-41C3-BFE2-14055D0A9A38

Q50547545-C9EC81D8-3410-4D08-9A69-FE19F8C9CDC6

P304

Q50547545-924C5674-435B-44C3-BA48-C387E47CB5A3

P31

Q50547545-3341B5E2-C771-4E91-BC49-4641C21644E1

P356

Q50547545-22561059-702B-4BD8-AC62-B9BDB2AE23BD

P433

Q50547545-10820685-9F77-4D55-B77D-488A0861BED5

P478

Q50547545-782FD83A-D450-4F0F-8FD3-29799258FEDF

P50

Q50547545-39E1CBD1-CE40-4BF9-9A7C-AD6064ADCE98

P577

Q50547545-4B3EC388-813D-4908-B07C-3F2D46B817FD

P5875

Q50547545-5D163F4C-7E3E-49DC-B92B-13723C726527

P698

Q50547545-F7C8E009-9B29-4E65-BF3E-A152DB41CF04

P921

Q50547545-AC3E8050-7787-4677-82ED-3B6BC124CA72

P356

02841860802004974

P1433

Acta Oncologica

P1476

BRCA1 and BRCA2 mutations in D ...... breast and/or ovarian cancer.

@en

P2093

Ake Borg

http://www.w3.org/2001/XMLSchema#string

Finn C Nielsen

http://www.w3.org/2001/XMLSchema#string

Friedrik Wikman

http://www.w3.org/2001/XMLSchema#string

Henriette Theilmann Lianee

http://www.w3.org/2001/XMLSchema#string

Inge Søkilde Pedersen

http://www.w3.org/2001/XMLSchema#string

Mads Thomassen

http://www.w3.org/2001/XMLSchema#string

Marie Luise Bisgaard

http://www.w3.org/2001/XMLSchema#string

Thomas V O Hansen

http://www.w3.org/2001/XMLSchema#string

Torben A Kruse

http://www.w3.org/2001/XMLSchema#string

P2860

BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations

Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysis.

A high proportion of founder BRCA1 mutations in Polish breast cancer families.

BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age.

Classification of BRCA1 missense variants of unknown clinical significance.

Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families.

Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer

Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.

Evaluation of two different models to predict BRCA1 and BRCA2 mutations in a cohort of Danish hereditary breast and/or ovarian cancer families.

Low frequency of large genomic rearrangements of BRCA1 and BRCA2 in western Denmark.

P304

772-777

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/02841860802004974

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P50

Anne-Marie Gerdes

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5386999

http://www.w3.org/2001/XMLSchema#string

P698

18465347

http://www.w3.org/2001/XMLSchema#string

P921